Palmitoyl Tetrapeptide-7 Potential Actions On Dermal Cells and Collagen Synthesis

Palmitoyl Tetrapeptide-7, also referred to as Pal-GQPR, is considered a tetrapeptide that may “stimulate collagen renewal and inhibit collagen degradation” in mammalian models according to the available research.⁽¹⁾ This tetrapeptide is described as a palmitoylated fragment of immunoglobulin G with the sequence GQPR (glycyl-l-glutamyl-l-prolyl-l-arginine). The peptide is palmitoylated at the N-terminus to form Pal-GQPR, as this may potentially improve its dermal cell permeation.⁽²⁾

Functionally, studies conducted in laboratory settings suggest that palmitoyl tetrapeptide-7 may have the potential to decrease the secretion of pro-inflammatory molecules like IL-6, may reduce inflammation after UVB exposure, and possibly to stimulate production of collagen as well as laminin IV and V. Researchers such as Resende et al. present it also as a peptide that may support the elasticity, firmness, and smoothness of dermal cell structures, possibly by promoting collagen fiber regeneration.⁽³⁾

 

Research

Palmitoyl Tetrapeptide-7 and Dermal Cell Structure

Unfortunately, most of the research on Palmitoyl Tetrapeptide-7 has evaluated the peptide as a part of blends with other peptides. For example, in a notable study by Mondon et al., palmitoyl tetrapeptide-7 is evaluated as part of a two-peptide blend together with palmitoyl oligopeptide.⁽⁴⁾

Nevertheless, these experiments appear to provide valuable information as the researchers suggest it may push dermal fibroblast systems toward higher production of extracellular matrix components and may also increase proteins that stabilize the epidermal–dermal junctions (EDJ). EDJs are structures that anchor epidermis to dermis and tend to weaken in aging cell cultures, especially when exposed to environmental stress.

In confluent dermal fibroblast cultures exposed to both peptides, the researchers noted apparent increases in secreted matrix markers, including an increase in the levels of collagen I by about +258%, fibronectin by +164%, and hyaluronic acid by +179% versus solvent controls. The authors also mention the peptide may have a supporting role in gene-level signals, suggesting higher expression for pro-collagen and matrix-associated genes such as lysyl oxidase, fibronectin, and laminin-related transcripts.

Palmitoyl Tetrapeptide-7 and Collagen Synthesis

Research by Yang et al. experimented with another Palmitoyl Tetrapeptide-7 blend, which also included palmitoyl tripeptide-1 and N-acetylneuraminic acid: In cultured dermal fibroblasts exposed for 24 hours to these peptides, the active complex apparently increased cell proliferation compared with control cells. Moreover, the authors assessed gene expression via quantitative PCR, and apparently observed that the mix messenger RNA (mRNA) for several extracellular matrix (ECM) structural components. An increase in mRNA is considered a significant signal for a consequent increase in the synthesis of the actual compounds. Specifically, there were increases in the mRNA for synthesis of collagen type I alpha 1 chain by 1.8-fold, collagen type III alpha 1 chain by 2.5-fold, and collagen type IV alpha 1 chain by 2.8-fold.

Elastin mRNA, which relates to elastic fiber formation, also apparently increased to about 5-fold versus control, and fibronectin mRNA, a matrix glycoprotein involved in matrix organization and cell adhesion, increased 1.6-fold. In addition to the mRNA data, Yang et al. used immunofluorescence staining, which labels specific proteins with antibodies and quantifies fluorescence intensity as a proxy for protein abundance in the cells.

In these dermal fibroblast cultures, staining signals for type I collagen, type III collagen, and elastin were higher after exposure to the peptide than in controls, suggesting the upregulated mRNA has indeed translated into higher synthesis. Following extended experimentation, the researchers also concluded that the peptide blend may have the potential to increase “hydration (28.12%), elasticity (18.81%), and collagen production (54.99%)”.

Palmitoyl Tetrapeptide-7 and Skin Cell Inflammation

One of the few studies focusing solely on Palmitoyl Tetrapeptide-7 is the research by Xing et al. In their publication, they describe the peptide as an IgG-derived fragment that may dampen excessive IL-6 output and may increase granulocyte chemotactic protein-2 (GCP-2), which the authors frame as a possible route toward faster transition out of chronic inflammation and into repair-associated phases.

Specifically, the researchers posit that Palmitoyl Tetrapeptide-7 may shift inflammatory signaling in macrophage-like cultures toward an anti-inflammatory phenotype, with lower IL-6 and TNF-α and higher IL-10. In endothelial-like assays, Palmitoyl Tetrapeptide-7 appears to support stem cells in terms of stronger migration and network readouts.

In an in vivo hyperglycemia-associated full-thickness wound model, the peptide was also apparently observed to improve closure over 95% by day 21 of experimentation and increase collagen deposition, alongside lower IL-6 and TNF-α staining and higher IL-10 and CD31 signals, which the authors interpret as reduced inflammatory burden with increased angiogenesis-related markers.

NOTE: These products are intended for laboratory research use only. This peptide is not intended for personal use. Please review and adhere to our Terms and Conditions before ordering.

 

References:

1. Zhao C, Li D, Li J, Wang L. [Molecular tandem repeat strategy for production ofultrashort peptides]. Sheng Wu Gong Cheng Xue Bao. 2022 Dec 25;38(12):4587-4600. Chinese. PMID: 36593195.https://doi.org/10.13345/j.cjb.220397
2. Mortazavi SM, Moghimi HR. Skin permeability, a dismissed necessity for anti-wrinkle peptide performance. Int J Cosmet Sci. 2022 Apr;44(2):232-248. doi: 10.1111/ics.12770. Epub 2022 Apr 28. PMID: 35302659.
3. Resende DISP, Ferreira MS, Sousa-Lobo JM, Sousa E, Almeida IF. Usage of Synthetic Peptides in Cosmetics for Sensitive Skin. Pharmaceuticals (Basel). 2021 Jul 21;14(8):702. doi: 10.3390/ph14080702. PMID: 34451799; PMCID: PMC8400021.
4. Mondon P, Hillion M, Peschard O, Andre N, Marchand T, Doridot E, Feuilloley MG, Pionneau C, Chardonnet S. Evaluation of dermal extracellular matrix and epidermal-dermal junction modifications using matrix-assisted laser desorption/ionization mass spectrometric imaging, in vivo reflectance confocal microscopy, echography, and histology: effect of age and peptide applications. J Cosmet Dermatol. 2015 Jun;14(2):152-60. doi: 10.1111/jocd.12135. Epub 2015 Mar 27. PMID: 25817264.
5. Yang F, Zhang X, Wang H, Guo M, Zhang J, Feng X, Yu J, Yang J, Zhu J, Wang Y. Comprehensive evaluation of the efficacy and safety of a new multi-component anti-aging topical eye cream. Skin Res Technol. 2024 Jul;30(7):e13790. doi: 10.1111/srt.13790. PMID: 38932444; PMCID: PMC11208285.
6. Xing C, Hou L, Sun C, Chen H, Li Y, Li L, Wu Y, Li L, An H, Wen Y, Du H. Injectable polypeptide/chitosan hydrogel with loaded stem cells and rapid gelation promoting angiogenesis for diabetic wound healing. Int J Biol Macromol. 2025 May;306(Pt 2):141578. doi: 10.1016/j.ijbiomac.2025.141578. Epub 2025 Feb 27. PMID: 40023432.